S 296 · 112th Congress 2011–2013, ended

Preserving Access to Life-Saving Medications Act

Introduced Feb 7, 2011 Originated Senate Sponsor Amy Klobuchar D-MN

Fact sheet Spreadsheet

Latest action · Feb 7, 2011 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 7, 2011
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Preserving Access to Life-Saving Medications Act - Amends the Federal Food, Drug, and Cosmetic Act to require a prescription drug manufacturer to notify the Secretary of Health and Human Services (HHS) of a discontinuance, interruption, or other adjustment of the manufacture of the drug that would likely result in a shortage of such drug. Requires: (1) six months notice of any discontinuance or planned interruption or adjustment, and (2) notice as soon as practicable after becoming aware of such interruption or adjustment in the case of any other interruption or adjustment. Applies this Act to any approved prescription drug that is not a product that was originally derived from human tissue and was replaced by a recombinant product.

Sets forth the types of adjustment for which a manufacturer must submit notice, including: (1) adjustments related to the supply of raw materials, (2) adjustments to production capabilities, (3) business decisions that may affect the manufacture of the drug, and (4) other adjustments as determined appropriate by the Secretary.

Cosponsors 30

Members who signed on, in the order they did. Signatures ran from Feb 7, 2011 to Apr 24, 2012; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-PARobert P. Casey Jr.OriginalFeb 7, 2011
D-CTRichard BlumenthalMar 9, 2011
D-MDBenjamin L. CardinMar 17, 2011
D-OHSherrod BrownApr 14, 2011
D-NYCharles E. SchumerMay 9, 2011
D-MTJon TesterMay 12, 2011
D-DEChristopher A. CoonsMay 16, 2011
D-CADianne FeinsteinMay 23, 2011
D-MNAl FrankenMay 24, 2011
D-MDBarbara A. MikulskiJun 6, 2011
D-RIJack ReedJun 29, 2011
R-MESusan M. CollinsSep 6, 2011
D-SDTim JohnsonSep 20, 2011
D-NMJeff BingamanSep 22, 2011
D-NYKirsten E. GillibrandOct 11, 2011
D-NVHarry ReidOct 18, 2011
D-LAMary L. LandrieuOct 18, 2011
D-MOClaire McCaskillOct 31, 2011
D-ORJeff MerkleyNov 2, 2011
D-WAMaria CantwellNov 15, 2011
D-MIDebbie StabenowJan 23, 2012
D-NHJeanne ShaheenJan 23, 2012
D-VAMark R. WarnerJan 30, 2012
I-VTBernard SandersFeb 15, 2012
D-NJFrank R. LautenbergFeb 27, 2012
D-ILRichard J. DurbinFeb 27, 2012
D-VTPatrick J. LeahyMar 6, 2012
D-NMTom UdallMar 14, 2012
D-FLBill NelsonMar 15, 2012
D-NDKent ConradApr 24, 2012

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Feb 7, 2011

Actions 2

Everything that happened, newest first.

  1. Feb 7, 2011Introduced in Senate
  2. Feb 7, 2011Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In the Congressional Record 2

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S106–S108Amy Klobuchar D-MN, Susan M. Collins R-MEJan 26, 2012
SenateDebate and remarks S6901Amy Klobuchar D-MNOct 31, 2011

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 5

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 112-885PRESCRIPTION DRUG SHORTAGES: EXAMINING A PUBLIC HEALTH CONCERN AND POTENTIAL SOLUTIONS98 pagesHealth, Education, Labor, and Pensions CommitteeDec 15, 2011
Serial No. 112-102DRUG SHORTAGE CRISIS: LIVES ARE IN THE BALANCE71 pagesOversight and Government Reform CommitteeNov 30, 2011
Serial No. 112-88EXAMINING THE INCREASE IN DRUG SHORTAGES166 pagesEnergy and Commerce CommitteeSep 23, 2011
S. Hrg. 112-866SECURING THE PHARMACEUTICAL SUPPLY CHAIN94 pagesHealth, Education, Labor, and Pensions CommitteeSep 14, 2011
Serial No. 112-01FUNDAMENTAL TAX REFORM155 pagesWays and Means CommitteeJan 20, 2011

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages.
Short Titles as Introduced
Preserving Access to Life-Saving Medications Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Feb 7, 2011Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.